Profusa Overview

  • Founded
  • 2009

Founded
  • Status
  • Private

  • Employees
  • 73

Employees
  • Latest Deal Type
  • Reverse Merger

  • (Announced)
  • Investors
  • 17

Profusa General Information

Description

Developer of tissue-integrating biosensors designed to assist continuous monitoring of body chemistry. The company's sensor measures tissue-oxygen perfusion in the clinical management of chronic wounds and also has a tissue-integrating scaffold, breaking the biocompatibility barrier, optical reader, and adaptable form factor for consumer and medical applications, enabling doctors to help patients to improve personal health and manage diseases easily.

Contact Information

Website
www.profusa.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Biotechnology
Primary Office
  • 5959 Horton Street
  • Suite 450
  • Emeryville, CA 94608
  • United States
+1 (415) 000-0000

Profusa Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Profusa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Reverse Merger 07-Nov-2022 0000 Announced Generating Revenue
10. Secondary Transaction - Private 01-Aug-2021 0000 Completed Generating Revenue
9. Later Stage VC 01-Jun-2021 0000 Completed Generating Revenue
8. Debt - PPP 06-Apr-2020 00.00 0000 Completed Generating Revenue
7. Grant 01-Jan-2019 00000 0000 Completed Generating Revenue
6. Later Stage VC (Series C) 14-Aug-2018 0000 0000 00000 Completed Generating Revenue
5. Grant 01-Jan-2018 00.00 0000 Completed Generating Revenue
4. Grant 06-Feb-2017 00.00 0000 Completed Generating Revenue
3. Grant 12-Jul-2016 $9.2M $16M Completed Generating Revenue
2. Later Stage VC (Series B) 16-Dec-2015 $13.2M $16M 000.00 Completed Generating Revenue
To view Profusa’s complete valuation and funding history, request access »

Profusa Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C1 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 5,293,175 $0.000100 8% $2.61 $2.61 1x $2.61 13.49%
Series A 4,350,314 $0.000100 8% $1.22 $1.22 1x $1.22 11.09%
To view Profusa’s complete cap table history, request access »

Profusa Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of tissue-integrating biosensors designed to assist continuous monitoring of body chemistry. The company's sen
Monitoring Equipment
Emeryville, CA
73 As of 2022
0000
000000000000 0000

000000

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incidi
0000000000 000000000
San Jose, CA
000 As of 0000
00000
00000000000 00000

000000

sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
0000000000 000000000
Or Yehuda, Israel
0 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Profusa Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
VitalConnect Venture Capital-Backed San Jose, CA 000 00000 00000000000 00000
000000000 00000000 Corporation Or Yehuda, Israel 0 000.00 000000000 000.00
0000 00000000 0000 Private Equity-Backed Portland, OR 00 000000000000
0000000 0000000000 Venture Capital-Backed Milpitas, CA 000 00000 0000000000 0 00000
00000000 0000000 0 Venture Capital-Backed Loos, France 00 000.00 0000000000 0 000.00
You’re viewing 5 of 17 competitors. Get the full list »

Profusa Patents

Profusa Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3176228-A1 Method and system for in vitro sensing of analytes Pending 21-Apr-2020 000000000
US-20210255378-A1 Optical filter device, system, and methods for improved optical rejection of high angle of incidence (aoi) light Pending 19-Feb-2020 000000000
CA-3147294-A1 Optical filter device, system, and method for improved optical rejection of out-of-band wavelengths Pending 20-Aug-2019 0000000000
AU-2020333849-A1 Optical filter device, system, and method for improved optical rejection of out-of-band wavelengths Pending 20-Aug-2019 0000000000
US-20220160263-A1 Optical filter device, system, and method for improved optical rejection of out-of-band wavelengths Pending 20-Aug-2019 A61B5/1459
To view Profusa’s complete patent history, request access »

Profusa Executive Team (14)

Name Title Board Seat Contact Info
Ben Hwang Ph.D Chairman & Chief Executive Officer
William McMillan Co-Founder, Head of Research, President and Chief Scientific Officer
Sandeep Yadav Chief Financial Officer
Bruce Smith Chief of Staff
Kerstin Rebrin Vice President of Medical Affairs & Clinical Development
You’re viewing 5 of 14 executive team members. Get the full list »

Profusa Board Members (7)

Name Representing Role Since
Andrew Ng Ph.D Self Board Member 000 0000
Ben Hwang Ph.D Profusa Chairman & Chief Executive Officer 000 0000
Joan Braddi Self Board Member 000 0000
Karen Liu Ph.D 3E Bioventures Capital Board Member 000 0000
Tom Gutshall CampVentures Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Profusa Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Profusa Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sand Hill Angels Angel Group Minority 000 0000 000000 0
Wealthing VC Club Venture Capital Minority 000 0000 000000 0
Jinpei Li Angel (individual) Minority 000 0000 000000 0
Maxim Ventures Corporate Venture Capital Minority 000 0000 000000 0
Tasly Holding Group Corporation Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »

Profusa Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 000 07-Nov-2022 0000000000 Special Purpose Acquisition Company (SPAC)
To view Profusa’s complete acquisitions history, request access »